Cognitive-behavioral adherence promotion program
BehavioralA culturally sensitive group cognitive behavioral therapy combined with adherence promotion.
NCT Number: NCT02639949
Nonadherence to medication is a major obstacle to successful treatment of renal transplant patients. This study has two primary aims. The first is to test whether a culturally sensitive cognitive-behavioral adherence promotion program could significantly improve medication adherence to tacrolimus prescription. Participants will be randomly assigned to either group CBT or to standard care. The second aim is to pilot a novel strategy of adherence measurement - unannounced telephone pill counts, which has been shown to be a valid and reliable means to measure medication adherence in other patient populations. Participants will be recruited from waiting area of the kidney transplant clinic at SUNY Downstate Medical Center in Brooklyn, NY. Three unannounced telephone pill counts will be conducted prior to start of the intervention in order to establish baseline adherence and three pill counts will be conducted post-intervention. Tacrolimus trough concentration levels will also be collected as an additional biological measure of adherence.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A culturally sensitive group cognitive behavioral therapy combined with adherence promotion.
Time frame: 3 months
Time frame: 3 months
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Nih
The Use of Random Telephone Calls to Measure Immunosuppressive Therapy Adherence in Patients With Renal Transplants
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04965935
Diabetes Mellitus, Diabetes Mellitus, Type 2
Toronto, Ontario, Canada
View Trial DetailsNCT02555566
Kidney Transplant Recipients
Rouen, France
View Trial DetailsNCT05077254
COVID-19, Coronaviridae Infections
San Diego, California, United States
View Trial DetailsNCT01150487
Kidney Transplant Recipients, Living Donors
Rochester, Minnesota, United States
View Trial Details